Autolus Therapeutics (AUTL) Payables (2017 - 2025)
Historic Payables for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $11.0 million.
- Autolus Therapeutics' Payables rose 67341.33% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 67341.33%. This contributed to the annual value of $2.0 million for FY2024, which is 181165.05% up from last year.
- Latest data reveals that Autolus Therapeutics reported Payables of $11.0 million as of Q3 2025, which was up 67341.33% from $5.4 million recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Payables registered a high of $11.0 million during Q3 2025, and its lowest value of -$783000.0 during Q3 2021.
- Over the past 5 years, Autolus Therapeutics' median Payables value was $1.1 million (recorded in 2021), while the average stood at $1.7 million.
- Per our database at Business Quant, Autolus Therapeutics' Payables tumbled by 25352.94% in 2021 and then soared by 195507.25% in 2024.
- Over the past 5 years, Autolus Therapeutics' Payables (Quarter) stood at $431000.0 in 2021, then grew by 23.2% to $531000.0 in 2022, then crashed by 80.6% to $103000.0 in 2023, then skyrocketed by 1811.65% to $2.0 million in 2024, then soared by 456.98% to $11.0 million in 2025.
- Its Payables was $11.0 million in Q3 2025, compared to $5.4 million in Q2 2025 and $4.5 million in Q1 2025.